Phenazocine: Difference between revisions

	WikiDoc Resources for Phenazocine
Articles
Most recent articles on Phenazocine Most cited articles on Phenazocine Review articles on Phenazocine Articles on Phenazocine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Phenazocine Images of Phenazocine Photos of Phenazocine Podcasts & MP3s on Phenazocine Videos on Phenazocine
Evidence Based Medicine
Cochrane Collaboration on Phenazocine Bandolier on Phenazocine TRIP on Phenazocine
Clinical Trials
Ongoing Trials on Phenazocine at Clinical Trials.gov Trial results on Phenazocine Clinical Trials on Phenazocine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Phenazocine NICE Guidance on Phenazocine NHS PRODIGY Guidance FDA on Phenazocine CDC on Phenazocine
Books
Books on Phenazocine
News
Phenazocine in the news Be alerted to news on Phenazocine News trends on Phenazocine
Commentary
Blogs on Phenazocine
Definitions
Definitions of Phenazocine
Patient Resources / Community
Patient resources on Phenazocine Discussion groups on Phenazocine Patient Handouts on Phenazocine Directions to Hospitals Treating Phenazocine Risk calculators and risk factors for Phenazocine
Healthcare Provider Resources
Symptoms of Phenazocine Causes & Risk Factors for Phenazocine Diagnostic studies for Phenazocine Treatment of Phenazocine
Continuing Medical Education (CME)
CME Programs on Phenazocine
International
Phenazocine en Espanol Phenazocine en Francais
Business
Phenazocine in the Marketplace Patents on Phenazocine
Experimental / Informatics
List of terms related to Phenazocine

Phenazocine
Clinical data
Synonyms	Fenazocina, Phenazocinum, DEA No. 9715
Routes of; administration	Oral
ATC code	N02AD02 (WHO) ;
Legal status
Legal status	AU: S9 (Prohibited) ; UK: Class A, Withdrawn ; US: Schedule II ;
Identifiers
	IUPAC name (2R,6R,11R)-6,11-Dimethyl-3-(2-phenylethyl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol;
CAS Number	127-35-5 ;
PubChem CID	14707;
ChemSpider	391631 ;
UNII	J0ND6N0AQC;
ChEMBL	ChEMBL46399 ;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C22H27NO
Molar mass	321.45588 g/mol
3D model (JSmol)	Interactive image;
	SMILES C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(CCN2CCc4ccccc4)C)O;
	InChI InChI=1S/C22H27NO/c1-16-21-14-18-8-9-19(24)15-20(18)22(16,2)11-13-23(21)12-10-17-6-4-3-5-7-17/h3-9,15-16,21,24H,10-14H2,1-2H3/t16-,21+,22+/m0/s1 ; Key:ZQHYKVKNPWDQSL-KNXBSLHKSA-N ;
(what is this?) (verify)

VisualWikitext

Latest revision as of 17:46, 8 April 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Phenazocine (brand names Prinadol, Narphen) is an opioid analgesic drug, which is related to pentazocine and has a similar profile of effects.

Effects of phenazocine include analgesia and euphoria, also may include dysphoria and hallucinations at high doses, most likely due to action at κ-opioid and σ receptors.^[1]

Phenazocine appears to be a much stronger analgesic with fewer side effects than pentazocine, probably due to a more favorable μ/κ binding ratio. Phenazocine is a much more potent analgesic than pentazocine and other drugs in the benzomorphan series, most probably due to the presence of an N-phenethyl substitution, which is known to boost μ-opioid activity in many classes of opioid analgesics.^[2]

Consequently phenazocine is some 4x the potency of morphine as an analgesic. Also it does not cause spasm of the sphincter of Oddi, making it more suitable than morphine for the treatment of biliary or pancreatic pain.^[3]

History

Phenazocine was invented in the 1950s.^[4]^[5] It was one of a number of benzomorphan opioids (including pentazocine, dezocine, and cyclazocine) developed in the search for non-addictive strong analgesics.

Phenazocine was once widely used, and was mainly supplied as 5 mg tablets of the hydrobromide salt for sublingual use (Narphen, Prinadol and other names), but its use was discontinued in the United Kingdom in 2001.^[6]

Phenazocine was briefly used in the United States but fell out of favour for the above-mentioned reasons;Template:Which^{[citation needed]} it remains a Schedule II substance under the Comprehensive Drug Abuse Control & Prevention Act (aka Controlled Substances Act) of 1970 (CSA) but is not manufactured; other Schedule II narcotics not in use in the United States include bezitramide and metopon. The DEA ACSCN for phenazocine is 9715 and its 2013 annual manufacturing quota was 6 grammes ^[7]

References

↑ Harris LS, Pierson AK (February 1964). "Some Narcotic Antagonists in the Benzomorphan Series". Journal of Pharmacology and Experimental Therapeutics. 143: 141–8. PMID 14163985.
↑ Feinberg AP, Creese I, Snyder SH (November 1976). "The opiate receptor: a model explaining structure-activity relationships of opiate agonists and antagonists". Proceedings of the National Academy of Sciences USA. 73 (11): 4215–9. doi:10.1073/pnas.73.11.4215. PMC 431391. PMID 186791.
↑ Hopton D. (January 1971). "Double-blind clinical trial of the analgesic effects of phenazocine hydrobromide (Narphen) compared with morphine sulphate in patients with acute abdominal pain". Gut. 12 (1): 51–4. doi:10.1136/gut.12.1.51. PMC 1411461. PMID 4929685.
↑ Clarke EG (August 8, 1959). "Identification of Phenazocine, a Potent New Analgesic". Nature. 184 (Suppl 7): 451–451. doi:10.1038/184451a0. PMID 13810504.
↑ Eckenhoff JE (May–June 1959). "Phenazocine, a new benzomorphan narcotic analgesic". Anesthesiology. 20 (3): 355–8. doi:10.1097/00000542-195905000-00016. PMID 13650222.
↑ "Monthly Release Terming and Coding Newsletter" (PDF). NHS Information Authority. February 2001. Retrieved 2008-01-11.^{[dead link]}
↑ http://www.deadiversion.usdoj.gov/fed_regs/quotas/2013/fr0620.htm

[Harris-1] Harris LS, Pierson AK (February 1964). "Some Narcotic Antagonists in the Benzomorphan Series". Journal of Pharmacology and Experimental Therapeutics. 143: 141–8. PMID 14163985.

[Feinberg-2] Feinberg AP, Creese I, Snyder SH (November 1976). "The opiate receptor: a model explaining structure-activity relationships of opiate agonists and antagonists". Proceedings of the National Academy of Sciences USA. 73 (11): 4215–9. doi:10.1073/pnas.73.11.4215. PMC 431391. PMID 186791.

[Hopton-3] Hopton D. (January 1971). "Double-blind clinical trial of the analgesic effects of phenazocine hydrobromide (Narphen) compared with morphine sulphate in patients with acute abdominal pain". Gut. 12 (1): 51–4. doi:10.1136/gut.12.1.51. PMC 1411461. PMID 4929685.

[Clarke-4] Clarke EG (August 8, 1959). "Identification of Phenazocine, a Potent New Analgesic". Nature. 184 (Suppl 7): 451–451. doi:10.1038/184451a0. PMID 13810504.

[Eckenhoff-5] Eckenhoff JE (May–June 1959). "Phenazocine, a new benzomorphan narcotic analgesic". Anesthesiology. 20 (3): 355–8. doi:10.1097/00000542-195905000-00016. PMID 13650222.

[discontinueUK-6] "Monthly Release Terming and Coding Newsletter" (PDF). NHS Information Authority. February 2001. Retrieved 2008-01-11.^{[dead link]}

[7] ttp://www.deadiversion.usdoj.gov/fed_regs/quotas/2013/fr0620.htm

[1]

[2]

[3]

[4]

[5]

[6]

[7]

@@ Line 52: / Line 52: @@
 }}
 __NOTOC__
 {{SI}}
 {{CMG}}
 ==Overview==
 '''Phenazocine''' (brand names '''Prinadol''', '''Narphen''') is an [[opioid analgesic]] [[pharmaceutical drug|drug]], which is related to [[pentazocine]] and has a similar profile of effects.
@@ Line 80: / Line 77: @@
 {{Analgesics}}
 {{Hallucinogens}}
-{{Opioidergics}}
-[[Category:Benzomorphans]]
-[[Category:Kappa agonists]]
 [[Category:Mu-opioid agonists]]
 [[Category:Phenols]]
 [[Category:Synthetic opioids]]
 [[Category:Drug]]

v t e Analgesic products (N02A, N02B)
Opioids See also: Opioids template	Alphaprodine · Anileridine · Buprenorphine · Butorphanol · Codeine · Dextromoramide · Dextropropoxyphene · Dezocine · Desomorphine · Diamorphine · Dihydrocodeine · Dihydromorphine · Fentanyl · Hydrocodone · Hydromorphone · Ketobemidone · Levorphanol · Meptazinol · Methadone · Morphine · Nalbuphine · Nicomorphine · Opium · Oxycodone · Oxymorphone · Pethidine · Pentazocine · Pethidine · Piminodine · Piritramide · Tilidine · Tramadol · Tapentadol
Salicylic acid and derivatives	Aspirin (Acetylsalicylic Acid) · Benorylate · Diflunisal · Ethenzamide · Magnesium Salicylate · Salicin · Salicylamide · Salsalate · See also: NSAIDs
Pyrazolones	Ampyrone/Aminophenazone · Metamizole · Phenazone
Cannabinoids	Cannabis · Tetrahydrocannabinol · AM404
Anilides	Paracetamol (acetaminophen) · Phenacetin · Propacetamol
Non-Salicylate Non-Steroidal Anti-Inflammatories See also: NSAIDs template	Template:Navbox subgroup
Atypical, Adjunct & Miscellaneous	Bicifadine · Clonidine · Cyclobenzaprine · Duloxetine · Flupirtine · Gabapentin · Nefopam · Orphenadrine · Trazadone · Ziconotide

Clinical data

Synonyms	Fenazocina, Phenazocinum, DEA No. 9715
Routes of administration	Oral
ATC code	N02AD02 (WHO)
Legal status
Legal status	AU: S9 (Prohibited) UK: Class A, Withdrawn US: Schedule II
Identifiers
IUPAC name (2R,6R,11R)-6,11-Dimethyl-3-(2-phenylethyl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol
CAS Number	127-35-5^N
PubChem CID	14707
ChemSpider	391631^N
UNII	J0ND6N0AQC
ChEMBL	ChEMBL46399^Y
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₂H₂₇NO
Molar mass	321.45588 g/mol
3D model (JSmol)	Interactive image
SMILES C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(CCN2CCc4ccccc4)C)O
InChI InChI=1S/C22H27NO/c1-16-21-14-18-8-9-19(24)15-20(18)22(16,2)11-13-23(21)12-10-17-6-4-3-5-7-17/h3-9,15-16,21,24H,10-14H2,1-2H3/t16-,21+,22+/m0/s1^N Key:ZQHYKVKNPWDQSL-KNXBSLHKSA-N^N
^NY (what is this?) (verify)

Phenazocine: Difference between revisions

Latest revision as of 17:46, 8 April 2015

Overview

History

References

Navigation menu